The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function
Open Access
- 28 May 1999
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 80 (8) , 1150-1155
- https://doi.org/10.1038/sj.bjc.6690479
Abstract
We compared the oestrogenic and anti-oestrogenic properties of the two well-known phyto-oestrogens, genistein and quercetin, on the oestrogen-sensitive breast cancer cell line MCF-7. Genistein exerted a biphasic effect on growth of MCF-7 cells, stimulating at low and inhibiting at high concentrations, whereas quercetin was only growth inhibitory. At doses which did not inhibit cell growth, respectively 5 and 1 microM, genistein and quercetin counteracted oestrogen- and transforming growth factor-alpha-promoted cell growth stimulation. Furthermore, genistein promoted transcription of the oestrogen-regulated genes pS2 and cathepsin-D, whereas quercetin interfered with the oestrogen-induced expression of the proteins. In in vitro binding experiments, genistein competed with oestradiol for binding to the oestrogen receptor (ER), but quercetin did not. Quercetin and genistein down-regulated cytoplasmic ER levels and promoted a tighter nuclear association of the ER, but only genistein was able to up-regulate progesterone receptor protein levels. In gel mobility assays, ER preincubation with oestradiol or with the two phyto-oestrogens led to the appearance of the same retarded band, excluding differences between the various complexes in binding to the consensus sequence. The data allowed us to conclude that quercetin acts like a pure anti-oestrogen, whereas genistein displays mixed agonist/antagonist properties, and to formulate a hypothesis on the possible mechanism of action of such phyto-oestrogens.Keywords
This publication has 36 references indexed in Scilit:
- The role of estrogens on the proliferation of human breast tumor cells (MCF-7)Published by Elsevier ,2003
- Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cellsin vitroNutrition and Cancer, 1997
- Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cellsCancer Letters, 1996
- Nuclear receptor coactivators and corepressors.Molecular Endocrinology, 1996
- Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones.Molecular Endocrinology, 1996
- Quercetin Down-Regulates Signal Transduction in Human Breast Carcinoma CellsBiochemical and Biophysical Research Communications, 1995
- Quercetin induces type‐II estrogen‐binding sites in estrogen‐receptor‐negative (MDA‐MB231) and estrogen‐receptor‐positive (MCF‐7) human breast‐cancer cell linesInternational Journal of Cancer, 1993
- Contested meanings of the menopauseThe Lancet, 1991
- Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoidsBritish Journal of Haematology, 1990
- Phytoestrogen Interaction with Estrogen Receptors in Human Breast Cancer Cells*Endocrinology, 1978